Halma buys ophthalmic instruments maker Surgistar for $90m.

Halma said on Monday that it has bought Surgistar as a bolt-on for its healthcare sector company, MicroSurgical Technology (MST), for $90m (£67m).

Halma
13 April 2026 07:39:17

Source: Sharecast

Founded more than 20 years ago and based in California, Surgistar designs and manufactures ophthalmic surgical instruments and devices.

Its product portfolio includes blades, cannulas and trephines, "which are manufactured using highly automated processes that help ensure consistent quality and sharpness".

Chief executive Marc Ronchetti said: "Surgistar's differentiated product range is highly complementary to MST's and further strengthens Halma's ophthalmic product offering. The acquisition enhances MST's manufacturing capabilities and supports its long-term growth through MST's existing direct and global channels.

"We are excited to see our existing companies expand their capabilities through bolt-on acquisitions and delighted to welcome Surgistar to Halma."

See latest RNS on Investegate

FTSE 100 ( UKX )

ISIN: N/A

Exchange: London Stock Exchange

Sell:

0.00

Buy:

0.00

Change: -49.48 ( -0.47 %)

Date:

15/04/2026 - 16:35

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.